As global markets navigate a mix of economic signals and investor sentiment, the Hong Kong market has shown resilience, with the Hang Seng Index recently gaining over 2%. This positive movement comes amid broader concerns about China's economic outlook and corporate earnings that have missed expectations. In this environment, identifying stocks with strong fundamentals and growth potential is crucial. Here are three undiscovered gems in Hong Kong that stand out for their promising prospects.

Top 10 Undiscovered Gems With Strong Fundamentals In Hong Kong

Name Debt To Equity Revenue Growth Earnings Growth Health Rating S.A.S. Dragon Holdings 60.96% 4.62% 10.02% ★★★★★★ Lion Rock Group 16.91% 14.33% 10.15% ★★★★★★ Changjiu Holdings NA 11.84% 2.46% ★★★★★★ Sundart Holdings 0.92% -2.32% -3.94% ★★★★★★ Tianyun International Holdings 10.09% -5.59% -9.92% ★★★★★★ Xin Point Holdings 1.77% 10.88% 22.83% ★★★★★☆ Chongqing Machinery & Electric 28.07% 8.82% 11.12% ★★★★★☆ HBM Holdings 52.89% 66.59% 31.70% ★★★★★☆ Time Interconnect Technology 212.50% 27.21% 15.01% ★★★★☆☆ Billion Industrial Holdings 3.63% 18.00% -11.38% ★★★★☆☆

Click here to see the full list of 174 stocks from our SEHK Undiscovered Gems With Strong Fundamentals screener.

We're going to check out a few of the best picks from our screener tool.

IVD Medical Holding

Simply Wall St Value Rating: ★★★★★☆

Overview: IVD Medical Holding Limited is an investment holding company that distributes in vitro diagnostic (IVD) products in Mainland China and internationally, with a market cap of HK$2.13 billion.

Operations: IVD Medical Holding generates revenue primarily from its Distribution Business (CN¥2.86 billion), followed by After-sales services (CN¥196.47 million) and Self-Branded Products Business (CN¥9.05 million).

IVD Medical Holding, a small-cap player in the healthcare sector, has shown promising growth with earnings climbing by 12.3% over the past year, outpacing the industry average of -11.6%. The company reported net income of CNY 125.29 million for H1 2024, up from CNY 103.01 million last year, reflecting high-quality earnings and strong EBIT coverage of interest payments at 20.8x. However, shareholders faced dilution in the past year due to a follow-on equity offering worth HKD 189.64 million in June 2024.

Click to explore a detailed breakdown of our findings in IVD Medical Holding's health report. Gain insights into IVD Medical Holding's past trends and performance with our Past report.SEHK:1931 Earnings and Revenue Growth as at Sep 2024

Dah Sing Banking Group

Simply Wall St Value Rating: ★★★★★☆

Overview: Dah Sing Banking Group Limited is an investment holding company that offers banking, financial, and related services in Hong Kong, Macau, and the People's Republic of China with a market cap of HK$9.69 billion.

Story Continues

Operations: Dah Sing Banking Group's primary revenue streams include Personal Banking (HK$2.68 billion), Corporate Banking (HK$853.60 million), and Treasury and Global Markets (HK$1.34 billion). Mainland China and Macau Banking contribute HK$176.27 million to the total revenue.

Dah Sing Banking Group's total assets stand at HK$262.4B, with equity of HK$33.6B. The bank has deposits totaling HK$214.6B and loans amounting to HK$141.9B, achieving a net interest margin of 2%. Despite a low allowance for bad loans at 1.9%, earnings surged by 32.3% last year, outpacing the industry average of 3.2%. Recently, the company announced an interim dividend of HKD 0.27 per share for the first half of 2024 and reported net income growth to HKD 1,396M from last year's HKD 1,112M.

Get an in-depth perspective on Dah Sing Banking Group's performance by reading our health report here. Evaluate Dah Sing Banking Group's historical performance by accessing our past performance report.SEHK:2356 Debt to Equity as at Sep 2024

Dah Sing Financial Holdings

Simply Wall St Value Rating: ★★★★★☆

Overview: Dah Sing Financial Holdings Limited is an investment holding company that offers banking, insurance, financial, and related services in Hong Kong, Macau, and the People’s Republic of China with a market cap of HK$7.57 billion.

Operations: Dah Sing Financial Holdings generates revenue primarily from Personal Banking (HK$2.68 billion), Treasury and Global Markets (HK$1.34 billion), and Corporate Banking (HK$853.60 million). The company also earns from its Insurance Business segment, contributing HK$246.25 million, and Mainland China and Macau Banking, which adds HK$176.27 million to its revenue streams.

Dah Sing Financial Holdings, a notable player in Hong Kong's financial sector, reported earnings growth of 42.5% over the past year, surpassing the industry average of 3.2%. Trading at 42.6% below its estimated fair value, it holds total assets of HK$272.4B and equity of HK$42.4B. With total deposits at HK$214.2B and loans amounting to HK$141.9B, it has an appropriate level of bad loans (1.9%). The company announced an interim dividend of HKD 0.92 per share for the first half of 2024 and recently appointed Derek Wong as vice chairman.

Navigate through the intricacies of Dah Sing Financial Holdings with our comprehensive health report here. Assess Dah Sing Financial Holdings' past performance with our detailed historical performance reports.SEHK:440 Debt to Equity as at Sep 2024

Next Steps

Unlock our comprehensive list of 174 SEHK Undiscovered Gems With Strong Fundamentals by clicking here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Ready To Venture Into Other Investment Styles?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SEHK:1931 SEHK:2356 and SEHK:440.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments